Cover Image
市場調查報告書

動靜脈瘺:全球臨床實驗趨勢

Arteriovenous Fistula Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 330939
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
動靜脈瘺:全球臨床實驗趨勢 Arteriovenous Fistula Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月28日 內容資訊: 英文 61 Pages
簡介

本報告提供動靜脈瘺相關臨床研究之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關上研究的進展,有潛力的藥劑比較等資訊。

簡介

  • 動靜脈瘺
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家臨床實驗數量
    • 歐洲的主要國家臨床實驗數量
    • 北美的主要國家臨床實驗數量
    • 中東·非洲的主要國家臨床實驗數量

G7各國臨床實驗數量:心血管疾病治療藥臨床實驗上動靜脈瘺的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心血管疾病治療藥臨床實驗上動靜脈瘺的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的受驗者

贊助商類別的臨床實驗數量

有潛力的贊助商

動靜脈瘺治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Shire Plc
    • Proteon Therapeutics, Inc.
    • CYATHUS EXQUIRERE Pharmaforschungs GmbH
    • Celladon Corporation
  • 有代表性的研究機關·醫院臨床實驗概要
    • California Institute of Renal Research
    • Capital Medical University
    • City Hospitals Sunderland NHS Foundation Trust
    • Department of Health, UK
    • Duke University
    • Emory University
    • Englewood Hospital and Medical Center
    • 日本腫瘤 IVR研究群組
    • National Cheng-Kung University Hospital
    • NHS Greater Glasgow and Clyde

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2649CTIDB

GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2015" provides data on the Arteriovenous Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriovenous Fistula. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arteriovenous Fistula. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Arteriovenous Fistula
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Arteriovenous Fistula
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Arteriovenous Fistula Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Arteriovenous Fistula
    • Apr 13, 2015: Proteon Therapeutics to Present at Two International Vascular Access Conferences
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Proteon Therapeutics, Inc.
      • Clinical Trial Overview of Proteon Therapeutics, Inc.
      • CYATHUS EXQUIRERE Pharmaforschungs GmbH
      • Clinical Trial Overview of CYATHUS EXQUIRERE Pharmaforschungs GmbH
      • Celladon Corporation
      • Clinical Trial Overview of Celladon Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • California Institute of Renal Research
      • Clinical Trial Overview of California Institute of Renal Research
      • Capital Medical University
      • Clinical Trial Overview of Capital Medical University
      • City Hospitals Sunderland NHS Foundation Trust
      • Clinical Trial Overview of City Hospitals Sunderland NHS Foundation Trust
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • Duke University
      • Clinical Trial Overview of Duke University
      • Emory University
      • Clinical Trial Overview of Emory University
      • Englewood Hospital and Medical Center
      • Clinical Trial Overview of Englewood Hospital and Medical Center
      • Japan Interventional Radiology in Oncology Study Group
      • Clinical Trial Overview of Japan Interventional Radiology in Oncology Study Group
      • National Cheng-Kung University Hospital
      • Clinical Trial Overview of National Cheng-Kung University Hospital
      • NHS Greater Glasgow and Clyde
      • Clinical Trial Overview of NHS Greater Glasgow and Clyde
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Proteon Therapeutics, Inc., 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by CYATHUS EXQUIRERE PharmaforschungsGmbH, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by California Institute of Renal Research, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by City Hospitals Sunderland NHS Foundation Trust, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Englewood Hospital and Medical Center, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Interventional Radiology in Oncology Study Group, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cheng-Kung University Hospital, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2015*

List of Figures

  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top